Outstanding Recoveries
- Home
- Outstanding Recoveries
Verdicts & Settlements
Since Milberg’s founding in 1965, the firm has recovered more than $50 billion for our clients while prompting meaningful changes in corporate governance.
Filter By
Select Practice Area
-
See More$3.2 Billion Settlement – Tyco International Securities Litigation
In re Tyco International Ltd., Securities Litigation, MDL 1335 (D.N.H.)Milberg served as Co-Lead Counsel in this litigation, which involved federal securities claims against Tyco and its former CEO, CFO, general counsel, and certain former directors arising out of alleged insider trading and the overstatement of billions of dollars in income. In 2007, the court approved a $3.2 billion settlement. -
See More$1.14 Billion Settlement – Nortel Networks Corp. Securities Litigation
In re Nortel Networks Corp. Securities Litigation, No. 01-1855 (S.D.N.Y.)Milberg served as Lead Counsel for the class and the court-appointed lead plaintiff, the Trustees of the Ontario Public Service Employees’ Union Pension Plan Trust Fund, in this federal securities class action. In January 2007, the court approved a settlement valued at more than $1.14 billion. -
See More$330+ Million Settlement – Rite Aid Corp. Securities Litigation
In re Rite Aid Corp. Securities Litigation, No. 99-1349 (E.D. Pa.)Milberg served as Co-Lead Counsel in this case, in which plaintiffs asserted federal securities fraud claims based on Rite Aid’s alleged failure to disclose material problems with its store expansion and modernization program resulting in artificially inflated earnings. The court-approved settlements totaled over $330 million. -
See More$580+ Million Settlement – Cathode Ray Tube (CRT) Antitrust Litigation
In re Cathode Ray Tube (CRT) Antitrust Litigation, MDL 1917 (U.S. District Court for the Northern District of California)Milberg represented indirect purchaser plaintiffs in this class action alleging an international conspiracy among defendants to keep prices for cathode ray tube (CRT) displays artificially high. Milberg had a significant discovery role in the prosecution of this class action with settlements exceeding $580 million. -
See More$75 Million Settlement – Irvine v. ImClone Systems, Inc.
Irvine v. ImClone Systems, Inc., No. 02-0109 (S.D.N.Y.)Milberg served as Co-Lead Counsel in this case, in which the plaintiffs alleged that ImClone misrepresented the likelihood that its drug, Erbitux, would be approved, thereby artificially inflating the price of ImClone stock. The court approved a $75 million cash settlement in 2005.
